Patent Assignment
Reel/Frame 042481/0051
Amended and Restated Intellectual Property Security Agreement
Recorded: 2017-05-16
Pages: 9
Assignor
PHARMING GROUP N.V.
Executed: 2017-05-15
Assignee
ORBIMED ROYALTY OPPORTUNITIES II, LP
601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK, NEW YORK, 10022
Covered Properties
(10)
Multiplying Bovine Embryos
Patent:
4,994,384 →
Application:
07/113,791 →
Parthenogenic Oocyte Activation
Patent:
5,496,720 →
Application:
08/016,703 →
Method of Cloning Bovine Embryos
Patent:
5,453,366 →
Application:
08/031,815 →
Parthenogenic Oocyte Activation
Patent:
6,194,202 →
Application:
08/610,744 →
Parthenogenic Oocyte Activation
Patent:
6,077,710 →
Application:
09/176,395 →
Development of Normal Offspring Form Oocytes Injected with Freeze-Dried Spermatozoa
Patent:
6,641,526 →
Application:
09/177,391 →
Mammalian Transgenesis by Intracytoplasmic Sperm Injection
Patent:
6,376,743 →
Application:
09/371,648 →
Initiation of Full Mammalian Oocyte Activation by Multiple Sperm Components
Patent:
6,593,139 →
Application:
09/478,848 →
In Vitro Activation of Mammalian Oocytes
Patent:
6,680,199 →
Application:
09/576,592 →
Ungulates Produced by Sequential Nuclear Transfer
Patent:
6,603,059 →
Application:
09/688,782 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Jan 25, 2013
From: ADVANCED CELL TECHNOLOGY, INC.; MYTOGEN, INC.
To: CAMOFI MASTER LDC; CAMHZN MASTER LDC
Reel/Frame 029698/0001 →
Release of Security Interest
Nov 24, 2014
From: CAMOFI MASTER LDC; CAMHZN MASTER LDC
To: ADVANCED CELL TECHNOLOGY, INC.; MYTOGEN, INC.
Reel/Frame 034421/0863 →
Security Interest
Dec 7, 2016
From: PHARMING GROUP N.V.
To: SILICON VALLEY BANK
Reel/Frame 040594/0031 →
Amended and Restated Intellectual Property Security Agreement
May 16, 2017
From: PHARMING INTELLECTUAL PROPERTY B.V.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 042481/0139 →
Release of Security Interest
Jan 28, 2020
From: ORBIMED ROYALTY OPPORTUNITIES II, LP
To: PHARMING GROUP N.V.; PHARMING TECHNOLOGIES B.V.; PHARMING INTELLECTUAL PROPERTY B.V.; BROEKMAN INSTITUUT B.V.
Reel/Frame 051722/0304 →